[{"address1": "955 Chesterbrook Boulevard", "address2": "Suite 110", "city": "Chesterbrook", "state": "PA", "zip": "19087", "country": "United States", "phone": "610 354 8840", "website": "https://www.trevena.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Ms. Carrie L. Bourdow", "age": 60, "title": "President, CEO & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1083155, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry  Shin", "age": 51, "title": "Executive VP, COO & CFO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 722788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark A. Demitrack M.D.", "age": 65, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 741345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howard A. Rockman M.D.", "title": "Scientific Founder, Consultant and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Catalano", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert T. Yoder", "age": 57, "title": "Senior VP, Chief Business Officer & Head of Commercial Operations", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 490639, "exercisedValue": 0, "unexercisedValue": 9545}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.0, "open": 2.1, "dayLow": 1.7, "dayHigh": 2.43, "regularMarketPreviousClose": 2.0, "regularMarketOpen": 2.1, "regularMarketDayLow": 1.7, "regularMarketDayHigh": 2.43, "forwardPE": -0.09471033, "volume": 7215, "regularMarketVolume": 7215, "averageVolume": 40685, "averageVolume10days": 6780, "averageDailyVolume10Day": 6780, "bid": 1.88, "ask": 2.29, "bidSize": 36100, "askSize": 43500, "marketCap": 1603514, "fiftyTwoWeekLow": 1.13, "fiftyTwoWeekHigh": 19.225, "fiftyDayAverage": 3.27554, "twoHundredDayAverage": 8.033685, "currency": "USD", "sharesOutstanding": 852933, "sharesShort": 59358, "sharesShortPriorMonth": 16173, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0696, "heldPercentInsiders": 0.0037599998, "heldPercentInstitutions": 0.1037, "shortRatio": 1.0, "shortPercentOfFloat": 0.070300005, "bookValue": -11.072, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "trailingEps": -56.5, "forwardEps": -19.85, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TRVN", "underlyingSymbol": "TRVN", "shortName": "Trevena, Inc.", "longName": "Trevena, Inc.", "firstTradeDateEpochUtc": 1391178600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ab31c962-bf5d-3c6b-b3ee-f6b5d965694f", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.88, "targetHighPrice": 125.0, "targetLowPrice": 75.0, "targetMeanPrice": 100.0, "targetMedianPrice": 100.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "revenuePerShare": 6.135, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-11"}]